Hepatera's Unattributed VC Round

Hepatera raised a round of funding on April 03, 2012.

Hepatera develops drugs for the prevention and treatment of liver diseases. The company develops Myrcludex B, a drug that is aimed at the treatment of chronic viral hepatitis B and D.…

Articles about Hepatera's Unattributed VC Round: